Get the Stockscreener App
14.21
2.40%
-0.35
After Hours:
14.21
Evolus Inc Stock (EOLS) Latest News
Global Jeuveau Market Insights 2025: Key Trends, Market Size, and Growth Forecast - EIN News
Barclays Raises Evolus (NASDAQ:EOLS) Price Target to $22.00 - MarketBeat
Stifel maintains Buy on Evolus, price target steady at $25 - MSN
Midday Stock Roundup: Virgin Galactic down 2.3% and 87% YoY - Orange County Business Journal
FY2029 Earnings Estimate for Evolus Issued By HC Wainwright - MarketBeat
HC Wainwright Weighs in on Evolus' Q4 Earnings (NASDAQ:EOLS) - MarketBeat
Evolus (EOLS) Surges 28.3%: Is This an Indication of Further Gains? - MSN
Evolus, Inc. (NASDAQ:EOLS) Soars 30% But It's A Story Of Risk Vs Reward - Simply Wall St
HC Wainwright Reaffirms "Buy" Rating for Evolus (NASDAQ:EOLS) - MarketBeat
4 Analysts Have This To Say About Evolus - Benzinga
Stifel maintains Buy on Evolus, price target steady at $25 By Investing.com - Investing.com South Africa
Evolus projects robust 2025 growth with upcoming product launches - MSN
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company’s Guidance - BioSpace
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why - Yahoo! Voices
Nasdaq Jumps 100 Points; Charles Schwab Profit Beats Estimates - Benzinga
Evolus Shares Surge 34% on Record Q4 Revenue and FDA Approval Ex - GuruFocus.com
Evolus (NASDAQ:EOLS) Receives Buy Rating from Needham & Company LLC - MarketBeat
Evolus (NASDAQ:EOLS) Shares Gap UpHere's What Happened - MarketBeat
Evolus shares surge on strong Q4 results and upbeat 2025 outlook - MSN
Evolus announces Q4 preliminary unaudited net revenue of $79M - MSN
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday - Benzinga
Evolus Shares Rise on Jump in Revenue -January 21, 2025 at 09:28 am EST - Marketscreener.com
Evolus Shares Rise on Jump in Revenue - MarketWatch
Evolus shares surge on strong Q4 results and upbeat 2025 outlook By Investing.com - Investing.com South Africa
Evolus projects robust 2025 growth with upcoming product launches By Investing.com - Investing.com UK
Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - BioSpace
Evolus Awards 15,332 RSUs to New Employees Under 2023 Inducement Plan - StockTitan
Trend Tracker for (EOLS) - Stock Traders Daily
Evolus: Still Bullish, But Business Faces Tricky Challenges In '25 (NASDAQ:EOLS) - Seeking Alpha
Evolus (NASDAQ:EOLS) Hits New 1-Year LowHere's Why - MarketBeat
Barclays PLC Buys 68,213 Shares of Evolus, Inc. (NASDAQ:EOLS) - MarketBeat
Possible Bearish Signals With Evolus Insiders Disposing Stock - Simply Wall St
Evolus stock touches 52-week low at $10.23 amid market shifts - Investing.com Nigeria
Evolus (NASDAQ:EOLS) Sets New 52-Week LowHere's What Happened - MarketBeat
EVOLUS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased E - PR Newswire
(EOLS) Technical Data - Stock Traders Daily
Barclays PLC Grows Stake in Evolus, Inc. (NASDAQ:EOLS) - MarketBeat
Evolus Inc (EOLS) Trading Down 3.61% on Dec 27 - GuruFocus.com
1.11%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):